Mechanistically, TGFBI propels cancer progression by activating αvβ5 integrin signaling, ultimately engaging Src, FAK, PI3K, and AKT through its RGD motif, as observed in models of osteosarcoma, colon, and pancreatic cancer12,14,15. The gene discussed is TGFBI; the disease is cancer.